Skip to main content
NC3Rs | 20 Years: Pioneering Better Science
Guidance

Endocrine disruptor assessment

Introduction

Many animals, typically fish, frogs and rats, are currently used in regulatory testing to determine whether manufactured chemicals cause endocrine disruption (ED) in humans and wildlife populations. Our work in this area aims to build the evidence base required to reduce the number of vertebrates used in in vivo studies  carried out to ensure the health of animals exposed to chemicals in the environment. We are leading a number of projects to ensure that the in vivo tests involved in ED assessment are as robust as possible, particularly focusing on aquatic species. This will reduce the need for tests to be repeated and the instances in which more complex and animal-intensive studies are triggered.. 

This work began with an expert workshop we co-hosted with the Health and Environmental Sciences Institute (HESI) in 2020. Read the report for an overview of the workshop discussions: Investigating endocrine-disrupting properties of chemicals in fish and amphibians: Opportunities to apply the 3Rs.

Fish vitellogenin assessment

Vitellogenin (VTG) in fish egg-yolk is commonly used to assess endocrine activity in ecotoxicological tests. VTG data can be highly variable, meaning that additional testing in fish may be required to address uncertainties in the VTG response. We are working to understand and address the causes of this variability, improve the robustness of VTG data and reduce unnecessary additional fish testing.

Find out more about this work on our project page: Identifying and addressing challenges in fish vitellogenin assessment.

Implications of proposed EU REACH requirements

We have led an analysis of the potential animal use and financial resource associated with new proposals for endocrine disruptor-specific information requirements in the European Union’s Registration, Evaluation, Authorisation and Restriction of Chemicals (EU REACH) Regulation.  A report on our analysis was shared with the EU Commission in June 2023 and subsequently published in a peer-reviewed journal article in August 2024. The key findings are that the proposed changes to endocrine disruptor assessment of chemicals in the EU could use tens of millions of animals, cost billions of euros and would not be feasible in practice. The project was supported by an expert working group across regulatory agencies, the agrochemical and industrial chemical industries and expert consultants, and co-funded by UK’s Department for the Environment and Rural Affairs (Defra) as well as the agrochemical company Corteva Agriscience and the trade association Concawe.

Ongoing projects in collaboration with HESI

We are currently leading several projects in collaboration with HESI and expert working groups to apply the 3Rs in aquatic ED tests:

  • A review of the current status and opportunities for improving aquatic ED in vivo test guideline studies.
  • Analysis of historical control data from amphibian metamorphosis assays and medaka extended one generation reproduction tests [1]. The outcome of these analyses will inform improvements in the design and performance of these tests and interpretation of the data.
  • Optimising concentration setting for aquatic ED in vivo tests. This data-driven project will provide recommendations and guidance to increase confidence in test results and maximise the utility of information generated, to avoid unnecessary additional vertebrate testing and suffering of test animals.

Publications

  1. Burden N et al, (2024). Resource and animal use implications of the proposed REACH information requirements for endocrine disruptor assessment. Regulatory Toxicology and Pharmacology 151:105671. doi:10.1016/j.yrtph.2024.105671
  2. Burden N et al, (2024). Control Performance of Medaka Extended One Generation Test Designs. Society of Toxicology Annual Meeting 2024, Salt Lake City, Utah, USA. Abstract/poster number 3919/P430. View poster online.
  3. Burden N et al, (2023). An international cross-laboratory survey on fish vitellogenin analysis: Methodological challenges and opportunities for best practice. Regulatory Toxicology and Pharmacology 145:105501. doi: 10.1016/j.yrtph.2023.105501
  4. Burden N et al, (2023). Are changes in vitellogenin concentrations in fish reliable indicators of chemical-induced endocrine activity? Ecotoxicology and Environmental Safety 266:115563. doi:10.1016/j.ecoenv.2023.115563
  5. Mitchell C et al, (2023). New Approach Methodologies for the Endocrine Activity Toolbox: Environmental Assessment for Fish and Amphibians. Environmental Toxicology and Chemistry doi: 10.1002/etc.5584
  6. Burden N et al, (2022). Investigating endocrine-disrupting properties of chemicals in fish and amphibians: Opportunities to apply the 3Rs. Integrated Environmental Assessment and Management, 18(2) 442-458. doi: 10.1002/ieam.4497
  7. Ortego L et al, (2021). The Extended Amphibian Metamorphosis Assay (EAMA): A thyroid-specific and less animal-intensive alternative to the Larval Amphibian Growth and Development Assay (LAGDA, OECD TG 241). Environmental Toxicology and Chemistry 40(8):2135-2144.  doi: 10.1002/etc.5078
  8. Wheeler JR et al, (2021). Hormone data collection in support of endocrine disruption (ED) assessment for aquatic vertebrates: Pragmatic and animal welfare considerations. Environment International 146:106287. doi: 10.1016/j.envint.2020.106287
  9. Lagadic L et al, (2019). Recommendations for reducing the use of fish and amphibians in endocrine-disruption testing of biocides and plant protection products in Europe. Integrated Environmental Assessment and Management 15:659-662. doi: 10.1002/ieam.4156

Keep up to date with the latest news from the NC3Rs Toxicology and Regulatory sciences programme.

Abstract close up of a 96-well plate